Original Research

The efficacy and safety of pemetrexed-based doublet therapy compared to pemetrexed alone for the second-line treatment of advanced non-small-cell lung cancer: an updated meta-analysis

Zhong AY, Xiong XL, Shi MH, Xu HJ

Drug Design, Development and Therapy 2015, 9:3685-3693

Published Date: 20 July 2015